GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Cyclically Adjusted PB Ratio

Addex Therapeutics (XSWX:ADXN) Cyclically Adjusted PB Ratio : 0.04 (As of Jun. 05, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-06-05), Addex Therapeutics's current share price is CHF0.0686. Addex Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was CHF1.73. Addex Therapeutics's Cyclically Adjusted PB Ratio for today is 0.04.

The historical rank and industry rank for Addex Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

XSWX:ADXN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.03   Max: 0.11
Current: 0.04

During the past years, Addex Therapeutics's highest Cyclically Adjusted PB Ratio was 0.11. The lowest was 0.02. And the median was 0.03.

XSWX:ADXN's Cyclically Adjusted PB Ratio is ranked better than
93.94% of 660 companies
in the Biotechnology industry
Industry Median: 1.745 vs XSWX:ADXN: 0.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Addex Therapeutics's adjusted book value per share data for the three months ended in Dec. 2023 was CHF0.009. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is CHF1.73 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Addex Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Addex Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Cyclically Adjusted PB Ratio Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.03

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.04 0.03 0.03

Competitive Comparison of Addex Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Addex Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Cyclically Adjusted PB Ratio falls into.



Addex Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Addex Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0686/1.73
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Addex Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Addex Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.009/106.4612*106.4612
=0.009

Current CPI (Dec. 2023) = 106.4612.

Addex Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
200906 0.000 101.608 0.000
200912 13.214 101.610 13.845
201006 10.294 102.102 10.733
201012 10.169 102.138 10.599
201106 6.465 102.678 6.703
201112 4.149 101.408 4.356
201206 2.483 101.596 2.602
201212 1.658 100.968 1.748
201306 0.334 101.466 0.350
201312 0.307 101.036 0.323
201406 0.208 101.517 0.218
201412 0.235 100.704 0.248
201506 0.249 100.464 0.264
201512 0.151 99.386 0.162
201606 0.104 100.088 0.111
201612 0.019 99.380 0.020
201706 0.180 100.285 0.191
201712 0.100 100.213 0.106
201806 1.603 101.435 1.682
201812 1.486 100.906 1.568
201903 0.000 101.571 0.000
201906 1.219 102.044 1.272
201909 0.000 101.396 0.000
201912 0.959 101.063 1.010
202003 0.817 101.048 0.861
202006 0.704 100.743 0.744
202009 0.594 100.585 0.629
202012 0.539 100.241 0.572
202103 0.608 100.800 0.642
202106 0.481 101.352 0.505
202109 0.391 101.533 0.410
202112 0.447 101.776 0.468
202203 0.342 103.205 0.353
202206 0.181 104.783 0.184
202209 0.150 104.835 0.152
202212 0.064 104.666 0.065
202303 0.050 106.245 0.050
202306 0.066 106.576 0.066
202309 0.040 106.570 0.040
202312 0.009 106.461 0.009

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Addex Therapeutics  (XSWX:ADXN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Addex Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (XSWX:ADXN) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021